• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Artemis Strategic Investment Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    9/14/23 5:00:20 PM ET
    $ARTE
    Blank Checks
    Finance
    Get the next $ARTE alert in real time by email
    0001839990 false 0001839990 2023-09-10 2023-09-10 0001839990 ARTEU:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember 2023-09-10 2023-09-10 0001839990 us-gaap:CommonClassAMember 2023-09-10 2023-09-10 0001839990 ARTEU:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockEachMember 2023-09-10 2023-09-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): September 14, 2023 (September 10, 2023)

     

    ARTEMIS STRATEGIC INVESTMENT CORP.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-40855   86-1303512
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    3310 East Corona Avenue

    Phoenix, Arizona 85040

    (Address of principal executive offices, including zip code)

     

    Registrant’s telephone number, including area code: (602) 346-0329

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on which
    registered
    Units, each consisting of one share of Class A common stock and one half of one redeemable warrant   ARTEU   The Nasdaq Stock Market LLC
    Class A common stock, par value $0.0001 per share   ARTE   The Nasdaq Stock Market LLC
    Warrants, each whole warrant exercisable for one share of Class A common stock, each   ARTEW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On September 10, 2023, Artemis Strategic Investment Corp., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the “Minimum Total Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Global Market.

     

    In accordance with Nasdaq Listing Rule 5810(c)(2)(A)(i), the Notice states that the Company has 45 calendar days, or until October 25, 2023, to submit a plan to regain compliance with the Minimum Total Holders Rule.

     

    If the Company is unable to regain compliance by that date, the Company intends to submit a plan to regain compliance with the Minimum Total Holders Rule within the required timeframe. If Nasdaq accepts the Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the Minimum Total Holders Rule. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.

     

    Forward Looking Statements

     

    This Current Report on Form 8-K includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations, including regaining compliance with the Minimum Total Holders Rule during any compliance period or in the future, otherwise meeting Nasdaq compliance standards, being granted by Nasdaq any relief from delisting as necessary, or ultimately meeting applicable Nasdaq requirements for any such relief. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    ARTEMIS STRATEGIC INVESTMENT CORP.  
       
    By: /s/ Philip Kaplan  
      Name: Philip Kaplan  
      Title: Co-Chief Executive Officer  

     

    Dated: September 14, 2023

     

     

     

    Get the next $ARTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARTE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ARTE
    SEC Filings

    View All

    SEC Form 15-12G filed by Artemis Strategic Investment Corporation

    15-12G - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/13/23 1:33:49 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Artemis Strategic Investment Corporation

    25-NSE - Artemis Strategic Investment Corp (0001839990) (Subject)

    11/3/23 4:17:54 PM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (Amendment)

    8-K/A - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/2/23 5:00:14 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Atlas Merchant Capital Llc claimed ownership of 621,621 shares

    3 - Artemis Strategic Investment Corp (0001839990) (Issuer)

    7/27/23 4:15:37 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Artemis Strategic Investment Corporation files Form S-4 in Connection with Its Business Combination with Danam Health, Inc.

    PHOENIX, AZ / ACCESSWIRE / September 18, 2023 / Artemis Strategic Investment Corporation (NASDAQ:ARTE), a publicly traded special purpose acquisition company ("Artemis"), today announced the filing of its registration statement on Form S-4 (the "Registration Statement") with the United States Securities and Exchange Commission ("SEC") in connection with Artemis' business combination with Danam Health, Inc. ("Danam"), a health services technology and pharmaceutical distribution company pioneering a healthcare ecosystem model designed to bring efficiency to the prescription journey and promote medication compliance.The Registration Statement contains a preliminary proxy statement and prospectu

    9/18/23 6:00:00 PM ET
    $ARTE
    Blank Checks
    Finance

    Danam Health, Inc. and Artemis Strategic Investment Corporation Announce the Execution of a Definitive Merger Agreement

    Danam Health, Inc. ("Danam") is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.Founded by a consortium of top-tier pharma executives dedicated to improving the last mile of medication and healthcare delivery, Danam aims to achieve commercial success by utilizing advanced integrative technology to overcome both cost- and geography-related patient access barriers.Danam leverages its proprietary technology to bridge the gap that exists among patients, practitioners, pharmacies, and pharmaceutical product accessibility by

    8/7/23 8:05:00 AM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation Announces Contribution to Trust Account in Connection with Proposed Extension; Clarifies that Trust Account Will Not Be Decreased Due to Excise Tax

    Phoenix, Arizona--(Newsfile Corp. - June 20, 2023) - Artemis Strategic Investment Corporation (NASDAQ:ARTEU) (NASDAQ:ARTE) (NASDAQ:ARTEW) (the "Company") announced today that it had filed a supplement ("Proxy Supplement") to its definitive proxy statement dated June 9, 2023 ("Proxy Statement") for the solicitation of proxies in connection with a special meeting of the Company's stockholders scheduled to be held on June 29, 2023 (the "Extension Meeting"), to consider and vote on, among other proposals, a proposal to extend the date by which the Company must consummate a business combination.The Proxy Supplement discloses that, if the Company's stockholders approve the proposed amendment to th

    6/20/23 4:15:00 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:55:24 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:47:18 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/9/24 11:59:40 AM ET
    $ARTE
    Blank Checks
    Finance